It is well established that there is no safe level of myopia and ocular disease including glaucoma, cataracts, choroidal neovascular membranes and retinal detachment present with myopia. The greater the amount of myopia, the higher the risk. [1].
Treatment options to prevent myopia progression include corneal reshaping/orthokeratology, pharmacological/atropine therapy, and soft multifocal contact lenses.
If you would like to read this complete article, please signup to become a member!
You do not have access to this post.
Great article! With utmost respect, I suggest that we don’t imply that myopia control will have effects on myopia-associated pathology. We can’t ignore the complex genetics involved. There is far more to myopia-associated glaucoma, cataract, and myopic retinal degeneration than our efforts to control axial length. A column on this will follow.